Delivery Order SPE2DB22D2206-SPE2DB23FJA53

Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $123
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $49,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 10mg methylphenidate tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 17-18, 2023. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA medical supply vehicle and will provide...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $17,580 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 100 tablets of 5 mg methylphenidate. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. As the DLA supports procurement for the Department of Defense, this delivery order is likely fulfilling...
The Defense Logistics Agency awarded a $277,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 20mg extended-release methylphenidate capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 23, 2023 through June 26, 2023. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S....
The Defense Logistics Agency awarded a $196,960 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 bottles containing 54 milligram extended release methylphenidate tablets. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. No major subcontractors or set aside designations were identified. As the DLA's mission involves provisioning medical supplies to support military...
The Defense Logistics Agency awarded a $277,770 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 40mg extended release methylphenidate capsules. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 7-8, 2023. As the DLA is the logistics combat support agency of the United States Department of Defense, this delivery order is likely supporting...
The Defense Logistics Agency awarded a $145,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 count bottles of 36mg methylphenidate ER tablets. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product from its Conshohocken, Pennsylvania facility to support DLA requirements. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA pharmaceutical supply...
The Defense Logistics Agency Troop Support Medical awarded a $167,360 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 90 bottles of 27mg methylphenidate extended release tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. No subcontractors or set aside designations were identified. This delivery order was issued against...
The Defense Logistics Agency awarded a $61,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 10 mg methylphenidate tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. As a major provider of pharmaceuticals to the Department of Defense, this delivery order supports DLA's procurement of medications for military treatment facilities on a short-term...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $944 to Amerisourcebergen Drug Corporation for the supply of 100 units of 20mg extended-release methylphenidate capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 14 to August 15, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $47,040 to Amerisourcebergen Drug Corporation to supply 100 capsules of 20mg methylphenidate controlled-release capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from September 13, 2023 through September 14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FJA53
    Delivery Order

The Defense Logistics Agency awarded a $122,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 10 mg methylphenidate tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6-7, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for this commonly prescribed stimulant medication, which is used to treat attention deficit hyperactivity disorder and narcolepsy. No set aside designation or subcontractors were identified.

Generated 12/20/23, 12:14 PM